310392-94-0 QM05G7NM4H MIN-117 free base UNII-QM05G7NM4H (alphaS)-4-(3,4-Dichlorophenyl)-alpha-(((2-(5-methyl-1,3,4-oxadiazol-2-yl)-4-benzofuranyl)oxy)methyl)-1-piperidineethanol 1-Piperidineethanol, 4-(3,4-dichlorophenyl)-alpha-(((2-(5-methyl-1,3,4-oxadiazol-2-yl)-4-benzofuranyl)oxy)methyl)-, (alphaS)- CAS 310392-94-0
Purity 97%+In StockPharmaceutical Standards
| CAS No. | 310392-94-0 |
| Molecular Formula | C25H25Cl2N3O4 |
| Molecular Weight | 502.39 g/mol |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
Chemical Structure
Description
High-purity 310392-94-0 QM05G7NM4H MIN-117 free base UNII-QM05G7NM4H (alphaS)-4-(3,4-Dichlorophenyl)-alpha-(((2-(5-methyl-1,3,4-oxadiazol-2-yl)-4-benzofuranyl)oxy)methyl)-1-piperidineethanol 1-Piperidineethanol, 4-(3,4-dichlorophenyl)-alpha-(((2-(5-methyl-1,3,4-oxadiazol-2-yl)-4-benzofuranyl)oxy)methyl)-, (alphaS)- (CAS 310392-94-0) pharmaceutical standards reference standard. Molecular formula: C25H25Cl2N3O4. Molecular weight: 502.39 g/mol. Produced by CATO, one of China's leading reference material manufacturers, with COA documentation and global shipping.
Physical & Chemical Properties
| Molecular Formula | C25H25Cl2N3O4 |
| Molecular Weight | 502.39 g/mol |
| Appearance | Pale yellow to yellow crystalline powder. (slight halide-like odor, low volatility) |
| Purity | 97%+ |
| Storage | Store in a cool place (≤25°C), protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 14.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 2025 |
| Halogen Content | Cl-containing |
| Nitrogen Atoms | 3 |
Recommended Standards
- Afatinib dichloro impurity (CAS 2223677-63-0)
- Afatinib Impurity 4 (CAS CATO-C4X-10064)
- (S)-6-(3-(tert-Butyl)-5-(3-(2,3-dichlorophenyl)ureido)-1H-pyrazol-1-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (CAS 897369-18-5)
- Diphenyl(quinolin-2-yl)methanol (CAS 30836-61-4)
- 2,5-Diethyl-1,3,4-thiadiazole (CAS 40928-84-5)
- 1,2,3-Tris(trifluoromethyl)benzene (CAS 42175-48-4)
- (E)-2-(4-chlorobenzylidene)-1,1-dimethylhydrazine (CAS 22699-29-2)
- 3-(2,5-Dimethylphenyl)-1-methyl-1h-pyrazol-5-amine (CAS 1152709-12-0)
- 1-Mesityl-5-((9-methyl-11-oxo-2,3,6,7-tetrahydro-1H,5H,11H-pyrano[2,3-f]pyrido[3,2,1-ij]quinolin-10-yl)methylene)pyrimidine-2,4,6(1H,3H,5H)-trione (CAS 840457-43-4)
- Epidermal Growth Factor Receptor Peptide (985-996) (CAS 96249-43-3)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 13829788188 / jacky.chen@cato-chem.com